IAS Stock Cash Flow Statements

Integral Ad Science Holding Corp Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Integral Ad Science Holding Corp Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30

cash flows from operating activities:
net income	16,408,000	7,993,000	15,271,000	16,089,000	7,690,000	-1,255,000	10,164,000	-13,749,000	7,677,000	3,146,000	11,486,000	767,000	1,961,000	1,159,000	-4,822,000	-9,783,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	17,242,000	16,463,000	16,934,000	16,243,000	15,709,000	15,080,000	14,593,000	14,027,000	13,521,000	12,825,000	12,811,000	12,617,000	12,510,000	12,458,000	17,188,000	16,100,000
stock-based compensation	18,844,000	15,525,000	12,577,000	16,443,000	15,004,000	15,738,000	15,462,000	13,900,000	40,435,000	11,306,000	11,645,000	14,247,000	10,721,000	8,139,000	9,093,000	8,142,000
foreign currency (gain) loss	-6,307,000	-2,486,000
deferred tax benefit	-6,194,000	-1,447,000	-960,000	-12,001,000	-3,451,000	-5,000	-3,557,000	19,561,000	-34,768,000	-2,767,000	-8,223,000	71,000	-9,000	-719,000	304,000
amortization of debt issuance costs	117,000	116,000	116,000	116,000	116,000	116,000	115,000	116,000	116,000	116,000	116,000	116,000	116,000	116,000	116,000	337,000
(reversal of) allowance for credit losses						-188,000
impairment of assets			133,000									6,000	0	49,000
changes in operating assets and liabilities:
decrease (increase) in accounts receivable										6,642,000		1,623,000	-7,981,000	-1,673,000
decrease in unbilled receivables	165,000	2,656,000			-2,169,000	3,167,000			980,000	1,292,000			990,000	649,000		-2,066,000
increase in prepaid expenses and other current assets	-2,728,000	-3,429,000	-54,000	880,000	-5,789,000	-13,759,000					-3,884,000	-2,197,000	-1,948,000	-2,612,000	2,534,000	-3,360,000
increase in operating leases	-501,000	-526,000	-392,000	-551,000	-416,000	-202,000					-350,000	-279,000
increase in other long-term assets			-1,089,000	-139,000						-19,000	-727,000	-4,000	-141,000	-185,000
decrease in accounts payable and accrued expenses and other long-term liabilities	11,153,000	-24,548,000			8,057,000	-28,278,000
increase in deferred revenue	395,000	-229,000	-385,000	879,000	-755,000	644,000	432,000	-200,000	-172,000	522,000		-94,000	48,000	173,000
increase in due to/from related party	2,000	10,000				-39,000	121,000	25,000	-165,000	47,000	-12,000	-34,000	74,000	34,000
net cash from operating activities	55,237,000	3,529,000	67,648,000	25,448,000	25,933,000	-1,131,000	57,505,000	22,052,000	29,110,000	22,956,000	24,907,000	24,355,000	12,018,000	11,187,000	25,939,000	4,600,000
capex	-160,000	-554,000	-190,000	-271,000	-195,000	-1,128,000	-21,000	-144,000	-528,000	-1,282,000	-1,099,000	-457,000	0	0	-319,000	-318,000
free cash flows	55,077,000	2,975,000	67,458,000	25,177,000	25,738,000	-2,259,000	57,484,000	21,908,000	28,582,000	21,674,000	23,808,000	23,898,000	12,018,000	11,187,000	25,620,000	4,282,000
cash flows from investing activities:
purchase of property and equipment	-160,000	-554,000	-190,000	-271,000	-195,000	-1,128,000	-21,000	-144,000	-528,000	-1,282,000	-1,099,000	-457,000			-319,000	-318,000
acquisition and development of internal use software and other	-11,080,000	-10,347,000				-9,163,000	-8,238,000	-8,611,000	-7,868,000	-7,060,000	-4,721,000	-3,828,000	-3,447,000	-2,677,000
net cash from investing activities	-11,240,000	-10,901,000	-10,082,000	-10,303,000	-9,868,000	-10,291,000	-9,225,000	-8,755,000	-8,396,000	-8,342,000	-5,820,000	-4,284,000	-5,183,000	-3,005,000	-23,241,000	-168,755,000
cash flows from financing activities:
repayment of long-term debt	-15,000,000	-20,000,000	-30,000,000	-30,000,000	-30,000,000	-30,000,000	-20,000,000	-20,000,000	-20,000,000	-85,000,000	-10,000,000	-15,000,000
proceeds from exercise of stock options			96,000	0	0	313,000	2,405,000	591,000			1,247,000	2,527,000
cash received from employee stock purchase program	827,000	1,232,000	884,000	116,000	820,000	1,393,000	924,000	827,000	622,000	787,000	457,000
net cash from financing activities	-14,173,000	-18,768,000	-29,020,000	-29,884,000	-29,180,000	-28,294,000	-16,671,000	-18,582,000	-16,500,000	-7,098,000	-8,276,000	-20,691,000	-9,102,000	598,000	6,983,000	156,322,000
net increase in cash, cash equivalents, and restricted cash			28,546,000	-14,739,000	-13,115,000	-39,716,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	2,037,000	597,000		971,000	-237,000	-847,000		-1,188,000	-447,000	305,000		-3,150,000	-2,524,000	278,000		-1,489,000
cash, cash equivalents and restricted cash at beginning of period	0	87,335,000		0	0	127,290,000		0	0	89,671,000		0	0	76,078,000		0
cash, cash equivalents, and restricted cash at end of period
supplemental disclosures:
net cash (received) paid during the period for:
interest	-408,000	-23,000	288,000	999,000	1,735,000	1,879,000	2,349,000	3,018,000	2,858,000	3,004,000		2,523,000	1,727,000	1,298,000		5,399,000
taxes	12,434,000	822,000	4,858,000	10,017,000	19,657,000	268,000	624,000	4,752,000	4,674,000	935,000		1,719,000	9,121,000	977,000		268,000
non-cash investing and financing activities:
property and equipment acquired included in accounts payable	-23,000	55,000	277,000	-61,000	106,000	2,000	414,000	-123,000	-293,000	433,000		-193,000	322,000	16,000		-116,000
internal use software acquired included in accounts payable	69,000	520,000		305,000	88,000	573,000	432,000	-147,000	-150,000	1,309,000		255,000	2,000	1,128,000
lease liabilities arising from right-of-use assets
reversal of credit losses		-1,134,000
increase in accounts receivable		-5,439,000	805,000	-4,958,000			11,788,000	-15,453,000
decrease in other long-term assets		4,000
net decrease in cash, cash equivalents, and restricted cash		-26,140,000
cash, cash equivalents and restricted cash at end of period		61,792,000				86,727,000		-6,473,000
lease liabilities arising from right of use assets		2,993,000		832,000	5,089,000	189,000	-23,048,000	-1,113,000	2,336,000	28,107,000		-2,008,000	572,000	27,650,000
foreign currency gain					169,000	1,395,000			-561,000	-678,000
allowance for credit losses			-928,000	204,000			1,593,000	969,000	740,000	514,000
employee retention tax credit											0
increase in unbilled receivables			-5,646,000				-4,315,000
increase in accounts payable and accrued expenses and other long-term liabilities			26,612,000
payment for acquisitions, net of acquired cash											0	1,000
repayment of short-term debt											20,000	49,000	49,000	-1,934,000
proceeds from the revolver							0	0	0	75,000,000
payments for repurchase of common stock											0
effect of exchange rate changes on cash and cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash, at beginning of year
cash, cash equivalents, and restricted cash, at end of year
net cash paid during the year for:
decrease in due to/from related party				3,000
development of internal use software and other				-10,032,000
cash, cash equivalents, and restricted cash, at end of period				-13,768,000						97,492,000		-3,770,000	-4,792,000	85,137,000		-9,322,000
net cash paid during the period for:
decrease in accounts receivable						6,436,000										-2,944,000
decrease (increase) in other long-term assets						19,000
loss on extinguishment of debt
facility exit costs
non-cash interest expense															0	-1,000
decrease (increase) in prepaid expenses and other current assets							567,000	-6,768,000	9,556,000	3,063,000
increase in accrued rent															40,000	92,000
proceeds from initial public offering, net of underwriting discounts and commissions															0
payments for offering costs															-2,505,000
payments for debt issuance costs															0
principal payments on capital lease obligations															-51,000	-56,000
cash paid for unit repurchases															1,000
cash paid during the year for:
conversion of members’ equity to additional paid-in capital																0
adjustments to reconcile net income to net cash from operating activities
foreign currency loss
decrease (increase) in operating leases								114,000	5,000	20,000
increase in accounts payable and accrued expenses												2,760,000				-2,632,000
net increase in cash, cash equivalents and restricted cash								-5,285,000	4,214,000	7,516,000		-620,000	-2,267,000	8,780,000		-7,833,000
cash paid during the period for:
decrease in accounts payable and accrued expenses									2,848,000	-13,073,000				-6,520,000
exercise of stock options										2,115,000				2,532,000	0	0
foreign exchange loss											1,730,000
allowance for doubtful accounts											1,190,000				2,260,000	665,000
write off of assets
decrease in deferred revenue																-186,000
extinguishment of debt
decrease (increase) in unbilled receivables
proceeds from the new revolver
deferred offering costs accrued, not yet paid																-450,000
allowance for (reversal of) doubtful accounts													171,000	314,000
initial public offering costs paid
operating leases														-195,000
(purchase of) proceeds from sale of property and equipment														-328,000
gain on sale of assets
impairment of internal use software
increase in due from related party
decrease in due to related party															-23,000
acquisition and development of internal use software															-2,691,000	-2,233,000
repayment of debt
proceeds from issuance of debt
changes in operating assets and liabilities, net of acquired business:
payment for the acquisition of publica, net of acquired cash
assets acquired under capital leases
deferred tax provision
increase in taxes receivable
increase in due to related party
cash paid for share repurchases

We provide you with 20 years of cash flow statements for Integral Ad Science Holding Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Integral Ad Science Holding Corp stock. Explore the full financial landscape of Integral Ad Science Holding Corp stock with our expertly curated income statements.

The information provided in this report about Integral Ad Science Holding Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.